Details for New Drug Application (NDA): 212423
✉ Email this page to a colleague
The generic ingredient in CYPROHEPTADINE HYDROCHLORIDE is cyproheptadine hydrochloride. There are six drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the cyproheptadine hydrochloride profile page.
Summary for 212423
Tradename: | CYPROHEPTADINE HYDROCHLORIDE |
Applicant: | Quagen |
Ingredient: | cyproheptadine hydrochloride |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 212423
Suppliers and Packaging for NDA: 212423
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CYPROHEPTADINE HYDROCHLORIDE | cyproheptadine hydrochloride | SYRUP;ORAL | 212423 | ANDA | QUAGEN PHARMACEUTICALS LLC | 70752-101 | 70752-101-12 | 473 mL in 1 BOTTLE, GLASS (70752-101-12) |
CYPROHEPTADINE HYDROCHLORIDE | cyproheptadine hydrochloride | SYRUP;ORAL | 212423 | ANDA | QUAGEN PHARMACEUTICALS LLC | 70752-185 | 70752-185-12 | 473 mL in 1 BOTTLE, PLASTIC (70752-185-12) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SYRUP;ORAL | Strength | 2MG/5ML | ||||
Approval Date: | May 22, 2019 | TE: | AA | RLD: | No |
Complete Access Available with Subscription